International Biotechnology Trust plc

Equities

IBT

GB0004559349

Investment Trusts

Market Closed - London S.E. 11:35:25 2024-05-13 EDT 5-day change 1st Jan Change
637 GBX +0.79% Intraday chart for International Biotechnology Trust plc -0.47% -0.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EARNINGS: International Biotechnology bullish; Andrews Sykes profit up AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 Revenue GBP650,000 MT
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 EPS GBX72.87 MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 29, 2024 CI
Transcript : International Biotechnology Trust plc - Special Call
International Biotechnology Trust plc commences an Equity Buyback Plan for 5,851,887 shares, representing 15.05% of its issued share capital, under the authorization approved on December 12, 2023. CI
International Biotechnology Trust plc Elects Gillian Elcock as Director CI
International Biotechnology Trust plc Declares Payment of A First Interim Dividend for the Year Ending 31 August 2023, Payable on 26 January 2024 CI
International Biotechnology Trust plc Approves Dividend Policy CI
International Biotechnology Trust plc's Equity Buyback announced on March 2, 2023, has expired. CI
Origin Enterprises kicks off EUR20 million buyback AN
EARNINGS: Wynnstay "optimistic" despite climate, dotdigital ups profit AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts FY23 Revenue GBP863,000 MT
International Biotechnology Trust plc Reports Earnings Results for the Full Year Ended August 31, 2023 CI
International Biotechnology Trust Selects Schroders as Fund Manager MT
International Biotechnology Trust plc Declares the Second Interim Dividend for the Period Ending 31 August 2023, Payable on 25 August 2023 CI
Grafenia "cautiously optimistic" about year ahead AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Reports H1 EPS GBX41.57 MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 28, 2023 CI
International Biotechnology Trust plc commences an Equity Buyback Plan for 6,124,285 shares, representing 14.99% of its issued share capital, under the authorization approved on December 6, 2022. CI
SV Health notifies International Biotechnology of termination in 2024 AN
Non-Standard drops on insolvency warning AN
International Biotechnology Trust's Investment Manager to Focus on Core Healthcare Business MT
TRADING UPDATES: Altona extends repayment; Kefi advances Saudi Arabia AN
UK dividends calendar - next 7 days AN
Chart International Biotechnology Trust plc
More charts
International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Company’s investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.37
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IBT Stock
  4. News International Biotechnology Trust plc
  5. Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Reports H1 EPS GBX41.57
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW